中医辨证治疗重型COVID-19后综合征1例
增强出版Severe Post-COVID-19 Syndrome Treated with Traditional Chinese Medicine: a Case Report and Literature Review
扫 描 看 全 文
1.山东中医药大学第二附属医院感染科,济南 250001
2.山东中医药大学附属医院急诊科,济南 266033
扫 描 看 全 文
闫瑢玓, 张飞虎, 连新宝. 中医辨证治疗重型COVID-19后综合征1例[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=34753074&Fpath=home&index=0
YAN Rongdi, ZHANG Feihu, LIAN Xinbao. Severe Post-COVID-19 Syndrome Treated with Traditional Chinese Medicine: a Case Report and Literature Review[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=34753074&Fpath=home&index=0
闫瑢玓, 张飞虎, 连新宝. 中医辨证治疗重型COVID-19后综合征1例[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=34753074&Fpath=home&index=0 DOI:
YAN Rongdi, ZHANG Feihu, LIAN Xinbao. Severe Post-COVID-19 Syndrome Treated with Traditional Chinese Medicine: a Case Report and Literature Review[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=34753074&Fpath=home&index=0 DOI:
病史摘要,2,慢性支气管炎病史32年,糖尿病病史10年,高血压病病史8年,甲状腺癌全切手术病史半年。2020年2月2日确诊新型冠状病毒肺炎。在急性感染期后陆续出现一系列症状:亚急性后遗症期症状主要为咳嗽、咳痰、乏力、焦虑、心慌等,慢性后遗症期闭经、脱发症状凸显。中医诊断 虚劳(脏腑亏虚 余邪羁留)西医诊断 COVID-19后综合征干预措施 后遗症期中医措施包括中药辨证治疗,同时指导穴位按摩、呼吸功能锻炼和八段锦等康复锻炼;住院期间西医措施包括对症治疗及无创呼吸机、面罩氧疗等支持治疗。疗效转归 经过一年多中医药康复治疗,身心状况均恢复良好。
Summary of case history, A history of chronic bronchitis for 32 years, diabetes for 10 years, and hypertension for 8 years; a total thyroidectomy due to thyroid cancer six months ago. She was diagnosed with COVID-19 on February 2. A variety of symptoms with a duration beyond the acute phase of COVID-19 presented as follows:cough,expectoration,fatigue,depresioon and palpitation during subacute phase of COVID-19;amenorrhea,loss of hair during chronic stage of post-acute COVID-19.,TCM diagnosis, Consumption(Visceral deficiency and Retention of pathogenic factor),Western medicine diagnosis, post-COVID-19 syndrome,Therapeutic methods, TCM therapies include Chinese herb medicine based on syndrome differentiation,acupoint massage and rehabilitation measures during post-acute COVID-19 such as pulmonary function rehabilitation and Baduanjin;Western therapies include symptomatic treatment and supportive therapy such as noninvasive ventilation and face mask oxygen.,Clinical outcomes, After more than one year's rehabilitation treatment with Traditional Chinese medicine, both physical and mental conditions recovered well.
新型冠状病毒肺炎COVID-19后综合征中医学康复
COVID-19post-COVID-19 syndromeChinese Medicinerehabilitation
Zhang L, Richards A, Khalil A, et al. SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome 1[J]. bioRxiv, 2020. doi:10.1101/2020.12.12.422516http://dx.doi.org/10.1101/2020.12.12.422516.
Gemelli Against COVID-19 Post-Acute Care Study Group. Post-COVID-19 global health strategies: the need for an interdisciplinary approach[J]. Aging Clin Exp Res, 2020, 32(8):1613-1620.
Forte G, Favieri F, Tambelli R, et al. COVID-19 Pandemic in the Italian Population: Validation of a Post-Traumatic Stress Disorder Questionnaire and Prevalence of PTSD Symptomatology[J]. Int J Environ Res Public Health, 2020, 17(11):4151.
SORIANO JB,MURTHY S,MARSHALL JC,et al. WHO Clinical Case Definition Working Group on Post-CO⁃ VID-19 Condition. A clinical case definition of post-COV⁃ ID-19 condition by a Delphi consensus[J]. Lancet Infect Dis,2022,22(4):e102-e107.
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study[J]. Lancet, 2021, 397(10270):220-232.
Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome[J]. Nat Med, 2021,27(4):601-615.
Baig AM. Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome[J]. ACS Chem Neurosci, 2020, 11:4017–4020.
Pfefferbaum B, North CS. Mental Health and the Covid-19 Pandemic[J]. N Engl J Med, 2020, 383:510–512.
National Insitute for Health and Care Excellence. SIGN. Royal College of General Practitioners COVID-19 Guideline Scope: Management of the Long-Term Effects of COVID-19[M]. NICE, London UK: 2020, pp.1–7.
Amenta EM, Spallone A, Rodriguez-Barradas MC, et al. Postacute COVID-19: An Overview and Approach to Classification[J]. Open Forum Infect Dis. 2020 Oct 21;7(12):ofaa509.
Sisó-Almirall A, Brito-Zerón P, Conangla Ferrín L, et al. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management[J]. Int J Environ Res Public Health, 2021, 18(8):4350.
Kissler SM, Tedijanto C, Goldstein E, et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period[J]. Science, 2020, 368(6493):860-868.
张玉,陈孝,张毕奎,等.新型冠状病毒肺炎临床合理用药专家共识[J].中国医院药学杂志,2020,40(6):593-605.
黄麟杰,陈富超,李志浩,等.新冠肺炎患者的药物治疗方案安全性分析[J].中国药理学通报,2020,36(5):737-738.
Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19[J]. Nat Med, 2020, 26(7):1017-1032.
Liu W, Guan WJ, Zhong NS. Strategies and Advances in Combating COVID-19 in China[J]. Engineering, 2020, 6(10):1076-1084.
中华人民共和国国家卫生健康委员会办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第七版) [J]. 中国医药, 2020, 15: 1494-1499.
李松桃,吴昊,李梓菡,等."清肺排毒汤"治疗新型冠状病毒肺炎的经方理论探析[J].成都中医药大学学报,2021,44(2):11-14.
张雯雯,柳越冬,陈萌,等.清肺排毒汤再识[J].光明中医,2020,35(9):1275-1279.
Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses[J]. Lancet, 2020, 395(10235):1517-20.
Al-Tawfiq JA, Memish ZA. What are our pharmacotherapeutic options for MERS-CoV? [J]. Expert Rev Clin Pharmacol, 2014, 7(3):235-238.
陈凡,邓体瑛,郭珩,等. 新型冠状病毒肺炎患者抗菌药物使用情况分析[J]. 医药导报,2020,9:1285-1288.
曹文静,张鹏,刘湘.抗菌药物在新型冠状病毒肺炎患者临床治疗中的合理使用[J].抗感染药学,2020,17(7):1072-1075.
梁力勉,武欣,简炎林,等. 治疗新冠肺炎抗病毒药物潜在相互作用横断面分析[J].今日药学,2021,31(6):443-448..
Wang X, Xu H, Jiang H, et al. Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study[J].QJM, 2020, 113(9):657-665.
王益斐,宣志红,周杨,等. 参麦注射液使用剂量与呼吸机相关性肺炎患者免疫功能及治疗效果的相关性研究[J].中国现代应用药学,2019,36(24):3085-3089.
刘清泉,夏文广,安长青,等.中西医结合治疗新型冠状病毒肺炎作用的思考[J].中医杂志,2020,61(6):463-464.
0
浏览量
17
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构